Global X S&P Biotech ETF (CURE) News Today → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free CURE Stock Alerts Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineModerna, Inc.: Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trialsfinanznachrichten.de - March 28 at 11:59 PMXBI: Biotech Is A Strong Buy As M&A Activity Picks Up (Rating Upgrade)seekingalpha.com - March 20 at 5:50 AMBiotech group backs anti-China bill; part ways with WuXi AppTecmsn.com - March 14 at 8:41 AMX-Therma's $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantationfinance.yahoo.com - March 13 at 8:20 PMKrystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updatesmarkets.businessinsider.com - February 26 at 9:57 AMSaudi Aramco and FT accused of running misleading ‘sustainable’ fuel advertsfinance.yahoo.com - February 22 at 3:00 PMLIXTE Biotechnology Shares Rise 14% After First Patient Dosed in LB-100 Trialmarketwatch.com - January 29 at 10:21 AMHuman Microbiome Therapeutics Market Size and Share Expected to Cross USD 3,917.01 Million By 2032, at 22.7% CAGR: Polaris Market Researchfinance.yahoo.com - January 11 at 12:37 PMU.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISSfinance.yahoo.com - January 11 at 7:36 AMGlobal $16.2B Research Antibodies & Reagents Market by Product, Technology, Application, End User & Region - Forecast to 2028finance.yahoo.com - January 10 at 2:55 PMBone Wax Market to Reach USD 107.8 billion by 2031, Rising at a CAGR of 3.3% | Transparency Market Research, Inc.finance.yahoo.com - January 10 at 3:28 AMDefence's AccuTOX(R) Impairs Lung Cancer Growthfinance.yahoo.com - January 10 at 3:28 AMGlobal Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030markets.businessinsider.com - January 9 at 11:55 AMEli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024msn.com - January 5 at 9:09 AMBiotechtech Stocks Find a Cure: M&Amsn.com - December 29 at 11:50 PMThese 3 Biotech Stocks Have Strong Upside Potential, Says Deutsche Bankmarkets.businessinsider.com - December 17 at 6:21 PMCheck out the renovations at the Kohler Waters Spamsn.com - December 13 at 7:58 AMHere's what to expect from Burning Rock Biotech's earnings reportmarkets.businessinsider.com - November 29 at 9:32 AMNew ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trademsn.com - November 22 at 8:32 AM7 Underappreciated Biotech Stocks to Pick Up on the Cheapmarkets.businessinsider.com - November 9 at 10:39 PMRobust Financial Performance and Promising Gene Therapy Pipeline Bolster Krystal Biotech’s Buy Ratingmarkets.businessinsider.com - November 7 at 8:33 AMCidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Resultsmarkets.businessinsider.com - November 2 at 5:39 PMIntellia Therapeutics Will Soon Make Biotech History. Is the Stock a Buy?fool.com - October 28 at 7:35 AMGlobal X ETFs Ranked Among Best Places to Work in New York by Crain's New York Businessbenzinga.com - September 28 at 3:45 PM5 Best Pharma ETFsinsidermonkey.com - September 12 at 6:04 PMKrystal Biotech (KRYS) Receives a New Rating from Berenberg Bankmarkets.businessinsider.com - September 6 at 5:53 PMDiverse Biotech Announces New Patent Approval for Its PEMBROLIZUMAB Antibody Drug DBT-50201benzinga.com - August 30 at 8:02 AMAxcella Therapeutics Gets Patent for Long Covid Treatmentmarketwatch.com - August 30 at 8:02 AMBetter Therapeutics stock surges on ‘big milestone’ after FDA approves smartphone-based diabetes treatmentmsn.com - July 11 at 12:16 AMThese ETFs Let You Maximize Your Exposure To The Biotech Industry's Performance – Whether Positive Or Inversebenzinga.com - March 24 at 9:27 AMETFs to Play Biotech M&Athestreet.com - March 19 at 5:27 PMGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM), Earnings Estimates, EPS, and Revenuebenzinga.com - March 7 at 7:20 AMGlobal X Launches 2 ESG-Focused Covered Call ETFsnasdaq.com - February 24 at 2:57 PM7 Cheap But Risky Biotech Stocksbarrons.com - January 18 at 3:44 PMUpdate on Acticor Biotech's clinical developments with glenzocimab in the treatment of cardiovascular emergenciesbenzinga.com - January 11 at 6:26 PMGlobal Spinal Muscular Atrophy Treatment Market Report 2022: Sector to Reach $11.4 Billion by 2028 at a 17.8% CAGRbenzinga.com - January 9 at 1:38 PMBank of America just added these biotech stocks to its list of first-quarter pickscnbc.com - January 8 at 11:46 PMGlobal X Funds - Global X Genomics & Biotechnology ETF (NASDAQ: GNOM)fool.com - January 7 at 1:43 PM3 Advancements in Biotech Investors Should Look Out for in 2023nasdaq.com - January 5 at 3:10 PMGlobal X S&P Biotech ETF (CURE.AX)finance.yahoo.com - October 17 at 8:46 PMBIOTECH IS ONE OF THE FIRST TO USE REGULATION CROWDFUNDING TO HELP FIND A CURE FOR CHEMICAL ADDICTION.finance.yahoo.com - September 16 at 4:12 AMInnovation1 Biotech Appoints Frederick E. Pierce, II to its Board of Directorsfinance.yahoo.com - September 15 at 1:05 PMQurAlis to Present at 22nd Annual Biotech in Europe Forumfinance.yahoo.com - September 14 at 10:03 PMBiden signs executive order targeting biotech as he talks up 'cancer moonshot'morningstar.com - September 14 at 10:15 AMFierce Biotech names Strand Therapeutics as one of its "Fierce 15" Biotech Companies of 2022finance.yahoo.com - September 12 at 10:15 AMThe 33rd Annual 65 Roses Ladies Golf Classic is Fundraising for a Cure!benzinga.com - September 12 at 12:15 AMCould This Biosimilar Drug Candidate Be a Winner for Amgen?msn.com - September 9 at 4:32 PMCompugen to Participate in Upcoming Fierce Biotech Summitfinance.yahoo.com - September 7 at 8:23 AMThe Best Biotech Stock to Own in Septembermsn.com - September 6 at 11:23 AMMaine Auto Dealership Supports the Champion the Cure Challenge to Defeat Cancerbenzinga.com - September 3 at 6:49 PM Get Global X S&P Biotech ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for CURE and its competitors with MarketBeat's FREE daily newsletter. Email Address The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! CURE Media Mentions By Week CURE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CURE News Sentiment▼0.000.48▲Average News Sentiment CURE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CURE Articles This Week▼00▲CURE Articles Average Week Get Global X S&P Biotech ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for CURE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:CURE) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold[Urgent!] Generational Wealth GameplanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeYour Money is Not SafeAmerican AlternativeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.